Christopher Murphy
Directeur Financier/CFO chez THIRD HARMONIC BIO, INC.
Postes actifs de Christopher Murphy
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| THIRD HARMONIC BIO, INC. | Directeur Financier/CFO | 04/01/2024 | - |
Historique de carrière de Christopher Murphy
Anciens postes connus de Christopher Murphy
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | - | - |
Formation de Christopher Murphy
| University of Notre Dame | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 3 |
| Irlande | 2 |
Opérationnelle
| Director of Finance/CFO | 1 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| THIRD HARMONIC BIO, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
- Bourse
- Insiders
- Christopher Murphy
- Expérience
